The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases

Author:

Gong Sheng,Li Gang,Li Dan,Liu Yu,Wu BangguiORCID

Abstract

Purpose To compare the risk of developing subsequent primary lung cancer among cervical cancer patients and the general population. Methods Several databases were searched from inception to April 25, 2023. The standard incidence ratios (SIRs) with 95% confidence intervals (CIs) were combined to identify the risk for second primary lung cancer after cervical carcinoma. Subgroup analyses based on the follow-up period, age, degree of malignancy and source of SIR were conducted. All the statistical analyses were performed with STATA 15.0 software. Results A total of 22 retrospective studies involving 864,627 participants were included. The pooled results demonstrated that cervical cancer patients had a significantly greater risk for lung cancer than did the general population (SIR = 2.63, 95% CI: 2.37–2.91, P<0.001). Furthermore, subgroup analyses stratified by follow-up period (<5 years and ≥5 years), age (≤50 years and <50 years), and degree of malignancy (invasive and in situ) also revealed an increased risk of developing lung cancer among cervical carcinoma patients. Conclusion Cervical cancer patients are more likely to develop subsequent primary lung cancer than the general population, regardless of age, follow-up time or degree of malignancy. However, more high-quality prospective studies are still needed to verify our findings.

Funder

Chengdu High-level Key Clinical Specialty Construction Project

Publisher

Public Library of Science (PLoS)

Reference55 articles.

1. Cancer statistics, 2022;RL Siegel;CA: a cancer journal for clinicians,2022

2. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands;M Rebolj;International journal of cancer,2007

3. Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?;IM de Kok;International journal of cancer,2011

4. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019;MJ Kang;Cancer research and treatment,2022

5. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;C Xia;Chin Med J (Engl),2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3